A multi-center study of recombinant factor VIII (Recombinate): safety, efficacy and inhibitor risk in previously untreated patients with hemophilia A - Bray, G L; Gomperts, E D; Courter, S; Gruppo, R; Gordon, E; Manco-Johanson, M; Shapiro, A; Scheibel, E (Blood, 1994)
et al.